Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020

Chest

Volumn 147, Issue 1, 2015, Pages 31-45

  Ford, Earl S ^a   Murphy, Louise B ^a   Khavjou, Olga ^b   Giles, Wayne H ^a   Holt, James B ^a   Croft, Janet B ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABSENTEEISM; ADULT; AGED; ARTICLE; BODY BURDEN; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; COST CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; ETHNICITY; EVIDENCE BASED MEDICINE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HEALTH INSURANCE; HEALTH SERVICE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; MIDDLE AGED; MORBIDITY; MORTALITY; NURSING; PREVALENCE; SELF CARE; UNITED STATES; VERY ELDERLY; YOUNG ADULT; ADOLESCENT; COST OF ILLNESS; ECONOMICS; FORECASTING; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; COST OF ILLNESS; FEMALE; FORECASTING; HEALTH CARE COSTS; HEALTH EXPENDITURES; HUMANS; MALE; MEDICAID; MEDICARE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84920717687     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-0972     Document Type: Article

References (33)

1. Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance-United States, 1999-2011. Chest. 2013; 144 (1): 284-305.
2. Centers for Disease Control and Prevention (CDC). Chronic obstructive pulmonary disease among adults-United States, 2011. M MWR Morb Mortal Wkly Rep. 2012; 61 (46): 938-943.
3. Miniño AM, Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2008. Natl Vital Stat Rep. 2011; 59 (10): 1-126.
4. Guarascio AJ, Ray SM, Finch CK, Self TH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res. 2013; 5 : 235-245.
5. Jansson SA, Backman H, Stenling A, Lindberg A, Rönmark E, Lundbäck B. Health economic costs of COPD in Sweden by disease severity-has it changed during a ten years period? Respir Med. 2013; 107 (12): 1931-1938.
6. Løkke A, Hilberg O, Tønnesen P, Ibsen R, Kjellberg J, Jennum P. Direct and indirect economic and health consequences of COPD in Denmark: a national registerbased study: 1998-2010. BMJ Open. 2014; 4 (1): e004069.
7. National Institutes of Health, National Heart, Lung, and Blood Institute. Morbidity & Mortality: 2004 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute; 2004.
8. Morbidity & mortality: 2007 chartbook on cardiovascular, lung, and blood diseases. National Institutes of Health, National Heart, Lung, and Blood Institute website. http://www.nhlbi.nih.gov/resources/docs/07-chtbk.pdf. Accessed September 23, 2013.
9. Morbidity & mortality: 2009 chartbook on cardiovascular, lung, and blood diseases. National Institutes of Health, National Heart, Lung, and Blood Institute website. http://www.nhlbi.nih.gov/resources/docs/2009-ChartBook.pdf. Accessed September 17, 2013.
10. Morbidity & mortality: 2012 chartbook on cardiovascular, lung, and blood diseases. National Institutes of Health, National Heart, Lung, and Blood Institute website. http://www.nhlbi.nih.gov/resources/docs/2012-ChartBook-508.pdf. Accessed March 15, 2013.
11. Medical Expenditure Panel Survey. Agency for Healthcare Research and Quality website. http://www.ahrq.gov/index.html. Accessed December 3, 2013.
12. Tangka FK, Trogdon JG, Ekwueme DU, Guy GP Jr, Nwaise I, Orenstein D. Statelevel cancer treatment costs: how much and who pays? Cancer. 2013; 119 (12): 2309-2316.
13. Tangka FK, Trogdon JG, Nwaise I, Ekwueme DU, Guy GP Jr, Orenstein D. State-level estimates of cancer-related absenteeism costs. J Occup Environ Med. 2013; 55 (9): 1015-1020.
14. Trogdon JG, Tangka FK, Ekwueme DU, Guy GP Jr, Nwaise I, Orenstein D. Statelevel projections of cancer-related medical care costs: 2010 to 2020. Am J Manag Care. 2012; 18 (9): 525-532.
15. Heidenreich PA, Trogdon JG, Khavjou OA, et al; American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resus citation; Council on Cardiovascular Nursing; Council on the Kidney in Cardio vascular Disease; Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011; 123 (8): 933-944.
16. Dalal AA, Christensen L, Liu F, Riedel AA. Direct costs of chronic obstructive pulmonary disease among managed care patients. Int J Chron Obstruct Pulmon Dis. 2010; 5 : 341-349.
17. Dalal AA, Liu F, Riedel AA. Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009. Int J Chron Obstruct Pulmon Dis. 2011; 6 : 533-542.
18. Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008; 57 (45): 1226-1228.
19. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease website. http://www.goldcopd.org/guidelines-global-strategy-fordiagnosis-management.html. Updated 2013. Accessed March 15, 2013.
20. Qaseem A, Wilt TJ, Weinberger SE, et al; American College of Physicians; American College of Chest Physicians; American Thoracic Society; European Respiratory Society. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011; 155 (3): 179-191.
21. Breunig IM, Shaya FT, Scharf SM. Delivering cost-effective care for COPD in the USA: recent progress and current challenges. Expert Rev Pharmacoecon Outcomes Res. 2012; 12 (6): 725-731.
22. Akazawa M, Hayflinger DC, Stanford RH, Blanchette CM. Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease. Am J Manag Care. 2008; 14 (7): 438-448.
23. Simoens S. Cost-effectiveness of pharmacotherapy for COPD in ambulatory care: a review. J Eval Clin Pract. 2013; 19 (6): 1004-1011.
24. Farrero E, Escarrabill J, Prats E, Maderal M, Manresa F. Impact of a hospital-based home-care program on the management of COPD patients receiving long-term oxygen therapy. Chest. 2001; 119 (2): 364-369.
25. Poole PJ, Chase B, Frankel A, Black PN. Case management may reduce length of hospital stay in patients with recurrent admissions for chronic obstructive pulmonary disease. Respirology. 2001; 6 (1): 37-42.
26. Konetzka RT, Spector W, Limcangco MR. Reducing hospitalizations from longterm care settings. Med Care Res Rev. 2008; 65 (1): 40-66.
27. Rutten-van Mölken MP, Goossens LM. Cost effectiveness of pharmacological maintenance treatment for chronic obstructive pulmonary disease: a review of the evidence and methodological issues. Pharmacoeconomics. 2012; 30 (4): 271-302.
28. Brady TJ, Murphy L, O'Colmain BJ, et al. A meta-analysis of health status, health behaviors, and healthcare utilization outcomes of the Chronic Disease Self-Management Program. Prev Chronic Dis. 2013; 10 : 120112.
29. Zuvekas SH, Olin GL. Validating household reports of health care use in the medical expenditure panel survey. Health Serv Res. 2009; 44 (5 Pt 1): 1679-1700.
30. Cox BG, Iachan R. A comparison of household and provider reports of medical conditions. J Am Stat Assoc. 1987; 82 (400): 1013-1018.
31. US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics. Evaluation of National Health Interview Survey diagnostic reporting. Vital Health Stat 2. 1994; 2 (120): 1-116.
32. Johnson AE, Sanchez ME. Household and medical reports on medical conditions: National Medical Expenditure Survey. J Econ Soc Meas. 1993; 19 : 199-223.
33. Machlin S, Cohen J, Elixhauser A, Beauregard K, Steiner C. Sensitivity of household reported medical conditions in the medical expenditure panel survey. Med Care. 2009; 47 (6): 618-625.